Your browser doesn't support javascript.
loading
A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis.
Mehta, Gautam; Rousell, Sam; Burgess, Gary; Morris, Mark; Wright, Gavin; McPherson, Stuart; Frenette, Catherine; Cave, Matthew; Hagerty, David T; Spada, Alfred; Jalan, Rajiv.
Affiliation
  • Mehta G; Institute for Liver and Digestive Health, Royal Free Campus, UCL, London, UK.
  • Rousell S; Clinical Outcomes Solutions, Folkestone, UK.
  • Burgess G; Vectura Group PLC, Chippenham, UK.
  • Morris M; Clinical Outcomes Solutions, Folkestone, UK.
  • Wright G; Department of Gastroenterology, Basildon and Thurrock University Hospitals NHS Foundation Trust, Basildon, UK.
  • McPherson S; Liver Unit, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Frenette C; Department of Organ Transplantation, Scripps Green Hospital, San Diego, USA.
  • Cave M; Department of Medicine, University of Louisville School of Medicine, Louisville, USA.
  • Hagerty DT; Conatus Pharmaceuticals Inc., San Diego, USA.
  • Spada A; Conatus Pharmaceuticals Inc., San Diego, USA.
  • Jalan R; Institute for Liver and Digestive Health, Royal Free Campus, UCL, London, UK.
J Clin Exp Hepatol ; 8(3): 224-234, 2018 Sep.
Article in En | MEDLINE | ID: mdl-30302038
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: J Clin Exp Hepatol Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: India
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: J Clin Exp Hepatol Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: India